Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Optimark MRI Contrast Agent NSF Warning Updated November 10, 2009 AboutLawsuits Add Your Comments The makers of Optimark, a gadolinium-based MRI contrasting agent, are changing the warning label to indicate that Optimark should not be used by patients with severe kidney problems. The label change was made due to the increased risk a serious and potentially life threatening condition, known as nephrogenic systemic fibrosis (NSF), which can cause a hardening and thickening of the skin and other tissue throughout the body. Covidien PLC announced the label change on Monday, just a few weeks before an FDA advisory committee is scheduled to re-examine the risk of gadolinium side effects, and the “black box” warning that was placed on all MRI contrast agents in 2007. The FDA scheduled the meeting in response to mounting criticism that called for a stronger NSF warning for Omniscan, a different gadolinium-based contrast agent manufactured by GE Healthcare. Gadolinium-based contrasting agents (GBCAs) are often given to patients undergoing magnetic resonance imaging scans (MRIs) to improve the outcome of the scans, allowing doctors to distinguish blood vessels from nearby tissue. Gadolinium contrast agents were prescribed to more than 9.5 million patients in the United States in 2008. Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION For a small sub-set of the population with moderate to severe kidney problems, side effects of the MRI contrast agents have been linked to an increased risk of nephrogenic systemic fibrosis (NSF), which is also sometimes referred to as nephrogenic fibrosing dermopathy (NFD). The rare progressive disorder is associated with scarring of the skin and connective tissue, which can cause the skin to become thick, hard, rigid and coarse, severely restricting movement of the joints. It also results in scarring or fibrosis of other organs, and in many cases it is fatal. In May 2007, the FDA required the makers of all five types of gadolinium MRI contrast available at that time to add a “black box” warning about the risk of NSF among individuals with kidney problems. Although a boxed warning is the strongest that can be placed on a prescription medication, critics have argued that the NSF warning for GE’s Omniscan should be worded stronger than the others, specifically indicating that it should not be used by those with severe kidney failure, as opposed to only cautioning doctors about the risk of NSF. The vast majority of cases of nephrogenic systemic fibrosis identified in the United States have been associated with the use of GE’s Omniscan, although it only accounts for about 30% of the market share. In a statement issued Monday, Covidien PLC, which manufacturers the competing Optimark contrast agent, announced that they are voluntarily contraindicating use of their gadolinium-based product in MRI procedures involving patients with severe renal impairment. They have submitted proposed label changes to the FDA, indicating that the drug should not be used in “patients with acute or chronic severe renal insufficiency (glomerular filtration rate of less than 30 mL/min /1.73m2) or acute renal insufficiency of any severity due to hepato-renal syndrome or in the perioperative liver transplant period.” The new label will go into effect immediately and apply in every country where Covidien sells the drug. GE Healthcare has resisted calls to place a similar contraindication on their Omniscan contrast agent, despite indications that the risk of NSF/NFD is greater with their product. There are currently about 400 nephrogenic systemic fibrosis lawsuits filed in state and federal courts throughout the United States against the makers of MRI contrast agents, including GE Healthcare (Omniscan), Bayer Healthcare (Magnevist), Bracco Diagnostics (MultiHance and ProHance) and Covidien (Optimark). The NSF lawsuits all allege that the manufacturers did not adequately research their product and failed to warn consumers about the risk of developing the debilitating and life-threatening condition. It has been estimated that about 75% of all NSF lawsuits involve plaintiffs who developed the condition after use of Omniscan, according to a report by ProPublica, far exceeding their market share for gadolinium MRI contrast agents. An FDA advisory committee is scheduled to re-examine the NSF warnings for gadolinium-based contrast agents at a meeting scheduled for December 8, 2009. Tags: Bayer, Gadolinium, Magnevist, MRI, MRI Contrast Agent, Nephrogenic Fibrosing Dermopathy, Nephrogenic Systemic Fibrosis, Omniscan Image Credit: | More Gadolinium Lawsuit Stories Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022 Gadolinium-Based MRI Contrast Agents Linked To Hypersensitivity Reactions: Study February 23, 2022 Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022
Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)